Skip to content
NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

Healthpeak Properties, Inc. DOC

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.8B
▲ 4.5% YoY
$71.3M
▼ 70.7% YoY
$357.0M
▲ 7.0% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Healthpeak Properties, Inc. owns, operates, and develops real estate focused on healthcare discovery and delivery in the United States. The company is headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts, and property management offices in several locations throughout the United States. As of December 31, 2025, its portfolio of investments consisted of interests in 689 properties, comprising 507 outpatient medical properties, 145 lab properties, 34 senior housing properties, and 3 other non-reportable properties. The outpatient medical segment includes outpatient medical buildings and hospitals; outpatient medical buildings typically contain physicians' offices and examination rooms, and may also include pharmacies, hospital ancillary service space, and outpatient services such as diagnostic centers, rehabilitation clinics, and day-surgery operating rooms. Its lab properties, which contain laboratory and office space, are leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. Within the lab segment, properties are located in geographical markets including San Francisco, California (59%), Boston, Massachusetts (22%), and San Diego, California (17%), based on total square feet. Its senior housing segment includes life plan communities and its SWF SH JV, an interest in an unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets. The company was originally founded in 1985.

Written from the business description in HEALTHPEAK PROPERTIES, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 3 February 2026. Every sentence was checked against that document before publication.

Growth

USD 2.8B
Revenue, FY2025 · full 19-year series below
Revenue $B Net income $B
FY2025 · Revenue 2.8 · Net income 0.1
1.0B2.0B-0.2B-0.4B
2007201020132016201920222025
Compound annual growth
+11.0%
+11.4%
+3.8%
+5.6%
−47.8%
−29.6%
−9.7%
−52.3%
−33.5%
−14.2%
+0.6%
−3.8%
−6.0%
−2.8%
+9.7%
+3.5%
−1.0%
+3.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +11.4% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

4 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating · · Net 3.6%
50%-10%-20%
200720162025
ROE
FY2025 · ROE 0.9%
5%10%15%-2%-4%
200720162025
Three returns, three denominators.
Return on capital employedNot available: we don't have total assets or current liabilities for this period.

Each USD of equity produced 1 cents of profit this year.

Cash & shareholders

USD 946.2M
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 0.4
0.5B1.0B
200720162025
Net buybacks $B Dividends $B
FY2025 · Dividends 0.8 · Net buybacks 0.1
0.5B1.0BDividendsNet buybacks
2007201020132016201920222025

USD 849.1M in dividends and USD 97.1M in buybacks — 1326% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 20.3B
EquityUSD 7.5B
CashUSD 467.5M
Gross debtUSD 9.8B
Net debtUSD 9.4B

Net debt stands at 125% of equity.

The 19-year record

19 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
DOC, 19-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B2.82.72.22.11.91.61.21.21.82.11.91.62.11.91.71.21.11.11.0
Operating income $B◌◌◌◌◌◌−0.0−0.00.00.00.0−0.0◌◌◌◌◌◌◌
EBITDA $B◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Income tax $B0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.00.0−0.00.00.00.00.00.0
Net income $B0.10.20.30.50.50.40.01.10.40.6−0.60.91.00.80.50.30.10.40.6
Free cash flow $B0.40.30.2−0.10.0−0.00.20.30.40.80.81.11.00.90.60.50.40.40.0
EPS, diluted $0.100.360.560.920.930.770.092.240.881.34−1.212.002.131.901.291.000.401.792.70
Dividend / sh $1.221.201.201.201.201.481.481.481.482.102.262.182.102.001.921.861.841.821.78
Payout %1190327215129129190158266168156−18710999104146179393102◌
ROE %0.93.34.77.67.66.50.818.97.68.4−5.68.69.18.56.34.82.49.3◌
Shares out B0.700.700.550.550.540.540.510.480.470.470.470.460.460.450.410.370.290.25◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 56 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. One check was skipped: the balance sheet is not tagged before 2008. One check was skipped: cost of revenue is not tagged before 2008.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityReal Estate Investment Trusts
Listed onNYSE
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image